IP Verse

Sanofi-Aventis Groupe S.A. vs. Amgen Inc. - APL_572929/2023

Explore detailed information on the case number APL_572929/2023 involving Sanofi-Aventis Groupe S.A., Regeneron Pharmaceuticals Inc., Sanofi Winthrop Industrie S.A., and others and Amgen Inc. which was filed on 13 Sep, 2023.

Case Details

    Case Number:

    APL_572929/2023

    Filing Date:

    13 Sep, 2023

    Proceeding Type:

    Appeal

    Action/Application:

    Appeal Rop220.2

    Decision Number:

    Ecli:Eu:Up:2023:580110

    Decision Date:

    16 Oct, 2023

    Plaintiffs:

    • Sanofi-Aventis Groupe S.A. Represented By Niels Hoelder
    • Regeneron Pharmaceuticals Inc. Represented By Niels Hoelder
    • Sanofi Winthrop Industrie S.A. Represented By Niels Hoelder
    • Sanofi-Aventis Deutschland Gmbh Represented By Niels Hoelder

    Defendants:

    • Amgen Inc. Represented By Johannes Heselberger

    Judges:

    • Ingeborg Simonsson
    • Patricia Rombach
    • Rian Kalden

    Court Division:

    Appeal Instance - Seat - Luxembourg

Case Decision

    Decision Date:

    Oct 13, 2023

    Decision Document:

More cases on Sanofi-Aventis Groupe S.A.

No cases found - set alert to stay updated on new cases

More cases on Amgen Inc.

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Aug 21, 2025
Case NumberFiling DatePlaintiffsDefendants
APL_32715/2025Jul 14, 2025Regeneron Pharmaceuticals, Sanofi BiotechnologiesAmgen, Amgen, Amgen Europe, Amgen, Amgen, Amgen, Amgen
ORD_16586/2025Apr 4, 2025Regeneron Pharmaceuticals, Sanofi BiotechnologiesAmgen, Amgen, Amgen Europe, Amgen, Amgen, Amgen, Amgen
ACT_10334/2025Feb 28, 2025Regeneron Pharmaceuticals Inc., Sanofi Biotechnology SasAmgen S.R.L., Amgen S.A.S., Amgen Nv, Amgen Gmbh, Amgen Inc., Amgen Europe B.V., Amgen B.V.